These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2171165)

  • 1. Protection of kidney from postischemic reperfusion injury in rats treated with defibrotide.
    Marni A; Ferrero ME; Rovati M; Salari PC; Gaja G
    Transplant Proc; 1990 Oct; 22(5):2226-9. PubMed ID: 2171165
    [No Abstract]   [Full Text] [Related]  

  • 2. Improved metabolic function of rat heart during procurement using defibrotide.
    Ferrero ME; Marni A; Aimini R; Bergamasco E; Gaja G
    Transplant Proc; 1990 Oct; 22(5):2230-2. PubMed ID: 2171166
    [No Abstract]   [Full Text] [Related]  

  • 3. Usefulness of defibrotide treatment during organ procurement and preservation in rats.
    Ferrero ME; Marni A; Salari PC; Parise M; Spaggiari PG; Gaja G
    Transplant Proc; 1991 Oct; 23(5):2359-61. PubMed ID: 1926386
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of defibrotide treatment in favoring the function of the grafted heart and kidney in rats.
    Ferrero ME; Corsi M; Marni A; Gaja G
    Transplant Proc; 1994 Feb; 26(1):251-2. PubMed ID: 8108964
    [No Abstract]   [Full Text] [Related]  

  • 5. Possible role of defibrotide in endothelial cell protection.
    Corsi M; Parise M; Gaja G; Ferrero ME
    Int J Tissue React; 1993; 15(4):157-61. PubMed ID: 8188455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defibrotide, a profibrinolytic drug, reduces damage due to post-ischaemic reperfusion in rats.
    Ferrero ME; Marni A; Gaja G
    Biochem Soc Trans; 1990 Jun; 18(3):501-2. PubMed ID: 2373250
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of impaired liver metabolism due to ischemia in rats. Efficacy of defibrotide administration.
    Ferrero ME; Marni A; Gaja G
    J Hepatol; 1990 Mar; 10(2):223-7. PubMed ID: 2332594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiischaemic effect of defibrotide treatment in rat kidney.
    Corsi M; Parise M; Gaja G; Ferrero ME
    Drugs Exp Clin Res; 1993; 19(6):261-5. PubMed ID: 8013269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defibrotide use during preservation favors the metabolic function of grafted kidneys in rats.
    Ferrero ME; Corsi M; Parise M; Marni A; Gaja G
    Transplant Proc; 1993 Aug; 25(4):2531-3. PubMed ID: 8356656
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostacyclin release from endothelial cells, induced by defibrotide treatment, favours the function of grafted rat hearts and kidneys.
    Ferrero ME; Marni A; Salari PC; Spaggiari PG; Gaja G
    Int J Tissue React; 1991; 13(4):215-8. PubMed ID: 1821415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defibrotide, a stimulator of prostacyclin (PGI2) production, prevents the effects of ischaemic damage.
    Ferrero ME; Marni A; Rovati M; Aimini R; Salari PC; Gaja G
    Int J Tissue React; 1989; 11(4):179-84. PubMed ID: 2517498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel beneficial mechanisms of defibrotide, a prostacyclin enhancing agent in splanchnic artery occlusion and reperfusion in rats.
    Ma XL; Porta R; Pescador R; Lefer AM
    Methods Find Exp Clin Pharmacol; 1991 Dec; 13(10):667-74. PubMed ID: 1663194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of rat kidney from ischemia reperfusion injury by oligotide.
    Marni A; Forti D; Cavillo L; Gaja G; Ferrero ME
    Transplant Proc; 1996 Feb; 28(1):297-300. PubMed ID: 8644230
    [No Abstract]   [Full Text] [Related]  

  • 14. Involvement of free radicals in the cardioprotective effect of defibrotide.
    Haklar G; Erşahin C; Moini H; Süngün M; Doğan N; Bilsel S; Emerk K; Yalçin AS
    Arzneimittelforschung; 1996 Apr; 46(4):381-4. PubMed ID: 8740083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of rat heart from damage due to ischemia-reperfusion during procurement and grafting by defibrotide.
    Ferrero ME; Marni A; Parise M; Salari PC; Gaja G
    Transplantation; 1991 Oct; 52(4):611-5. PubMed ID: 1926339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reduction of renal reperfusion damage following warm ischemia by allopurinol and superoxide dismutase].
    Marx A; Heberer M; Gale J; Landmann J
    Helv Chir Acta; 1989 Dec; 56(4):539-42. PubMed ID: 2632482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The enhancement of cellular cAMP with olprinone protects autotransplanted rat kidney against cold ischemia-reperfusion injury.
    Zhang Y; Ma Q
    Transplant Proc; 2006 Jun; 38(5):1580-3. PubMed ID: 16797361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of trimetazidine on the nucleotide profile in rat kidney with ischemia-reperfusion injury.
    Domanski L; Sulikowski T; Safranow K; Pawlik A; Olszewska M; Chlubek D; Urasinska E; Ciechanowski K
    Eur J Pharm Sci; 2006 Mar; 27(4):320-7. PubMed ID: 16387483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical effectiveness of defibrotide in vaso-occlusive disorders and its mode of actions.
    Ulutin ON
    Semin Thromb Hemost; 1988; 14 Suppl():58-63. PubMed ID: 2848323
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention of vascular graft lesions in renal transplant recipients with a new antithrombotic agent (defibrotide): a controlled study.
    Frascà GM; Vangelista A; Raimondi C; Bonomini V
    Life Support Syst; 1986; 4(3):231-7. PubMed ID: 3537545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.